Target intelligence / Profile preview

LRRC32 antisense RNA 1 (LRRC32-AS1)

Target
LRRC32-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

LRRC32 antisense RNA 1 (LRRC32-AS1) is a long non-coding RNA transcribed from the antisense strand of the LRRC32 locus. It belongs to the class of antisense lncRNAs, molecules that may regulate the expression of their sense gene (here, LRRC32 encoding Glycoprotein A Repetitions Predominant, or GARP) or potentially act on other targets at the transcript or chromatin level[1][3][5]. While the biological role of LRRC32-AS1 itself remains uncharacterized in the referenced literature, it is structurally typical of nuclear antisense lncRNAs, which are increasingly recognized as regulators of gene transcription, chromatin organization, and possibly cell phenotype in health and disease[3][5]. No direct evidence links LRRC32-AS1 specifically to known diseases, drug interactions, or clinical biomarker roles at this time[1].

02

Mechanism of action

Not applicable; no drugs reported to target LRRC32-AS1 directly[1].

03

Biological functions

Gene expression regulation (cis or trans regulation of neighboring or distant genes)[1]Potential modulation of the immune response (through regulation of inflammatory genes, based on analogy with other antisense lncRNAs)[3][5]Regulation of chromatin structure and transcription (typical for nuclear antisense lncRNAs)[3][5]
04

Disease associations

Cancer (regulation of cancer-related gene expression by antisense lncRNAs is described, but specific data for LRRC32-AS1 are not established in supplied sources; the gene is catalogued in cancer databases)[3][5][1]Other (lncRNAs are implicated in a variety of disease processes, but no direct disease role established for LRRC32-AS1 specifically in the provided sources)[1]

Beyond the preview

Go deeper on LRRC32 antisense RNA 1 (LRRC32-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LRRC32 antisense RNA 1 (LRRC32-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call